1. Lithium
Lithium remains a cornerstone in the treatment of bipolar disorder, offering mood stabilization for many patients. However, its narrow therapeutic window requires careful monitoring because prolonged lithium use can lead to chronic kidney damage. The kidneys are responsible for clearing lithium, but the drug can accumulate and cause nephrogenic diabetes insipidus and interstitial nephritis, which impair kidney function.
Signs of lithium-induced kidney injury often develop gradually and may be subtle initially. Patients on lithium therapy should regularly undergo serum lithium level checks, kidney function tests including serum creatinine, and urine analysis. Early detection is critical to preventing irreversible kidney damage.
- Regular monitoring of kidney function is essential.
- Hydration status must be maintained to prevent lithium toxicity.
- Any symptoms like increased urination, excessive thirst, or swelling should prompt medical evaluation.
Patients should never discontinue lithium without consulting their prescribing physician, as abrupt cessation can trigger mood destabilization. Instead, discuss any concerns about kidney health with a healthcare provider who can balance treatment benefits against risks.
2. Chemotherapy Drugs
Certain chemotherapy agents are well known for their nephrotoxic potential. Drugs such as cisplatin, carboplatin, mitomycin C, and bevacizumab can cause acute kidney injury by damaging renal tubular cells or by inducing vascular injury within the kidneys. Immunosuppressants like cyclosporine and tacrolimus, used in cancer and transplant patients, also carry significant risks for chronic kidney disease.
Because these medications are vital in treating life-threatening conditions, nephrotoxicity requires proactive management rather than avoidance. Strategies include dose adjustments, adequate hydration before and after chemotherapy, and close monitoring of kidney function through blood tests and urine output measurements.
- Hydration protocols reduce the risk of acute kidney injury.
- Regular monitoring of serum creatinine and electrolytes is critical.
- Alternative therapies may be considered if kidney function declines.
Oncologists and nephrologists often collaborate to optimize treatment plans that minimize kidney harm while effectively combating cancer.
3. Propylthiouracil
Propylthiouracil (PTU) is an antithyroid medication used primarily in hyperthyroidism management. Though effective in controlling thyroid hormone levels, PTU has been associated with rare but serious adverse effects on the kidneys, including vasculitis and glomerulonephritis. These immune-mediated reactions can cause inflammation and damage to the glomeruli, the filtering units of the kidney.
Patients on PTU should be monitored for symptoms such as blood in the urine, swelling, or unexplained fatigue, which may indicate kidney involvement. Laboratory tests including urinalysis and kidney function panels are necessary if nephrotoxicity is suspected.
- Regular thyroid and kidney function tests during therapy.
- Report any unusual symptoms promptly to a healthcare provider.
- Alternative treatments may be explored if kidney complications arise.
Because PTU is generally prescribed for specific thyroid conditions, any concerns should be addressed by an endocrinologist or the prescribing physician.
